US Patent 10023879 Minimal volume reprogramming of mononuclear cells
Patent 10023879 was granted and assigned to Fate Therapeutics Inc on July, 2018 by the United States Patent and Trademark Office.
Is a
Date Filed
June 4, 2015
Date of Patent
July 17, 2018
Patent Application Number
14731403
Patent Citations Received
•••
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10023879 Minimal volume reprogramming of mononuclear cells
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
